| |
|
|
Session 104
Poster Presentations HCV: Epidemiology, Natural History, Pathogenesis, and Impact on HCV Progression Wednesday 1:30 - 3:30 pm Hall B |
| 827 | Recent Trends in HIV-related Hospitalizations by Selected Diagnoses: A 12-state Study K. A. Gebo*1, J. A. Fleishman2, R. D. Moore1 1Johns Hopkins Univ, Baltimore, MD and 2Agency for Hlthcare Res and Quality, Rockville, MD |
| 828 | Impact of Hepatitis C, HIV, or Both on Survival in Veterans in Care Before and After the Introduction of HAART (1996) S. L. Fultz*1,2, A. C. Justice1,2, C. H. Chang2,3, A. A. Butt1,2, M. Skanderson1, D. Rimland4, M. O. Rigsby5,6 1Veterans Admin Pittsburgh Hlthcare Sys, PA; 2Univ of Pittsburgh Sch of Med, PA; 3Univ of Pittsburgh Graduate Sch of Publ Hlth, PA; 4Veterans Admin Med Ctr, Atlanta, GA; 5Publ Hlth Strategic Hlthcare Group, Veterans Admin, Washington, DC; and 6Yale Univ Sch of Med, New Haven, CT |
| 829 | The Association of Hepatitis C Virus Prevalence, Activity, and Genotype with HIV Infection in a Cohort of New York City Drug Users L. Strasfeld1, Y. Lo1, D. Netski2, D. L. Thomas2, R. S. Klein*1 1Montefiore Med Ctr, Albert Einstein Coll of Med, Bronx, NY and 2Johns Hopkins Sch of Med, Baltimore, MD |
| 830 | Histological Damage in Liver Biopsy Specimens from 492 HIV-HCV Co-infected Patients: A European Collaborative Study L. Martin-Carbonero*1, V. Soriano1, Y. Benhamou2, M. Puoti3, J. Rockstroh4, A. Arizcorreta5, J.A. Giron5, V. Asensi6, A. González7, M. Vogel4, J. Garcia-Samaniego1 1Inst de Salud Carlos III, Madrid, Spain; 2Hosp Pitié Salpêtrière, Paris, France; 3Spedali Civili, Brescia, Italy; 4Univ Hosp Bonn, Germany; 5Hosp Puerta del Mar, Cadiz, Spain; 6Hosp Gen Oviedo, Spain; and 7Ctrs Penitenciarios, Madrid, Spain |
| 831 | Progression of Liver Histological Status in HIV Hepatitis C Virus Co-infected Patients Started on HAART: A Prospective Study H. Zylberberg1, C. Barennes*2, F. Carnot3, M.-L. Chaix1, J.-P. Viard1, M. Savès2, G. Vona4, M. Bentata5, M. Diemer6, D. Zucman7, V. Baillat8, S. Pol1, C. Bréchot1, C. Rouzioux1, G. Chêne2 1Necker Hosp, Paris, France; 2INSERM U330, Bordeaux, France; 3Georges Pompidou Hosp, Paris, France; 4INSERM U370, Paris, France; 5Avicenne Hosp, Bobigny, France; 6Lariboisière Hosp, Paris, France; 7Foch Hosp, Suresnes, France; and 8Gui de Chauliac Hosp, Montpellier, France |
| 832 | High Frequency of CCR5- M. Zhang, J. J. Goedert, T. R. O'Brien* Natl Cancer Inst, Rockville, MD |
| 833 | Hepatitis C Virus Load Measured Prior to HIV Seroconversion is not Associated with Subsequent HIV Disease Progression in Injection Drug Users M. S. Sulkowski*1, J. Astemborski1, D. Vlahov1,2, S. A. Strathdee1, D. L. Thomas1 1Johns Hopkins Univ, Baltimore, MD and 2New York Academy of Med, New York |
| 834 | Soluble Cellular Adhesion Molecules in HIV+ Individuals Reflect Severity of HIV and HCV Disease, but Not Metabolic Risk Factors G. W. Beatty*1, J. W. Chu3, F. Abbasi3, M. Khalili1, J. Schmidt1, A. Vijay1, P. S. Tsao3, G. M. Reaven3 1Univ of California at San Francisco and 3Stanford Univ Sch of Med, Palo Alto, CA |
| 835 | A Model for Predicting Liver Fibrosis Using Non-invasive Biochemical Markers When Biopsy is Not Appropriate R Goodman*1, M French1, L Moorehead1, D Dieterich2, M Sulkowski3 1Hepatitis Resource Network, Puyallup, WA; 2Mt Sinai Sch of Med, New York, NY; and 3Johns Hopkins Med Inst, Baltimore MD |
| 836 | Hepatitis C Increases the Risk of DM in HIV-infected Veterans in Care A. A. Butt*1,2,3, A. C. Justice1,2,3, S. L. Fultz1,2,3 1Univ of Pittsburgh, PA; 2VA Pittsburgh Hlthcare Sys, PA; and 3Ctr for Hlth Equity Res and Promotion, Pittsburgh, PA |
| 837 | Frequent Detection of ex vivo CD8+ Responses against Hepatitis C Virus in HIV Co-infected Individuals on HAART A. Y. Kim*1, G. M. Lauer1, K. Ouchi1, C. L. Day1, R. T. Chung1, C. Corcoran1, M. A. Boczanowski1, A. Wurcel1, P. Klenerman2, Bruce D Walker1 1Partners AIDS Res Ctr, Charlestown, MA and 2Oxford Univ, UK |
| 838 | Pre-terminally Differentiated Hepatitis C-specific CD8+ T-cells Represent the Dominant Cell Population of Memory CD8 T-cells in Chronically Infected Patients M. Knuchel*, D. Ciuffreda, M. Khonkarly, M. Gillet, J-J. Gonvers, G. Pantaleo CHUV Lausanne, Switzerland |
| 839 | The Association of Hepatitis C Virus-specific Immune Responses with Liver Histology and Treatment Outcomes in Subjects with HIV/HCV Co-infection C. Graham*1, A. Wells1, T. Liu2, K. Sherman3, M. Peters4, R. Chung5, J. Andersen2, M. Koziel1, the ACTG 5071 Study Team6 1Beth Israel Deaconess Med Ctr and Harvard Med Sch, Boston, MA; 2Harvard Sch of Public Hlth, Boston, MA; 3Univ of Cincinnati, OH; 4Univ of California at San Francisco; 5Massachusetts Gen Hosp and Harvard Med Sch, Boston; and 6The AIDS Clin Trial Group |
| 840 | Plasma Cytokine Profiles during Acute Infection with HIV or Hepatitis C Virus B. Pappalardo*, M. Busch Blood Ctrs of the Pacific, San Francisco, CA |